Jr. Michael Conick Hanley - 20 May 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Chief Operating Officer
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol
ANRO
Transactions as of
20 May 2024
Net transactions value
$0
Form type
4
Filing time
22 May 2024, 17:19:12 UTC
Previous filing
24 Feb 2023
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Employee Stock Option (right to buy) Award $0 +188,000 $0.000000 188,000 20 May 2024 Common Stock 188,000 $12.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest on May 20, 2025, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.